Clinical trials
Recruiting Phase 3 Cognitive Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Donald Mabbott | 1 |
| HTA Co., Ltd. | 1 |
| Hoffmann-La Roche | 1 |
| Hospital Moinhos de Vento | 1 |
| Romanian Society for Enteral and Parenteral Nutrition | 1 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 1 |
| University Hospital, Lille | 1 |
| University of California, Irvine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 10 |
| Alzheimer Disease | 5 |
| Dementia | 3 |
| Diabetes Mellitus, Type 2 | 1 |
| Hip Fractures | 1 |
| Lymphoma, Follicular | 1 |
| Medulloblastoma | 1 |
| Postoperative Cognitive Complications | 1 |
| Stroke | 1 |
| Wounds and Injuries | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.